PAMU
TTPH

Pictet Asset Management (UK)’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Pictet Asset Management (UK)’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,335
Closed -$498K – 885
2015
Q3 		$498K Buy
3,335
+315
+10% +$231K ﹤0.01% 830
2015
Q2 		$2.87M Buy
3,020
+765
+34% +$625K 0.01% 702
2015
Q1 		$1.59M Buy
+2,255
New +$1.69M 0.01% 771

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Pictet Asset Management (UK)'s TTPH Position: Q4 2015 in Review

Pictet Asset Management (UK) sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2015, closing a stake of 3,335 shares — an estimated $498K sold.

Pictet Asset Management (UK) first reported a position in TTPH in Q1 2015 and held it in 3 quarters. The position peaked at $2.87M in Q2 2015. 105 funds tracked by Wall St. Rank hold TTPH as of Q4 2015.

  • Pictet Asset Management (UK) reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 3,335 Tetraphase Pharmaceuticals, Inc. shares in Q4 2015, an estimated $498K.
  • Pictet Asset Management (UK) first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and held it in 3 quarters.
  • Pictet Asset Management (UK)'s Tetraphase Pharmaceuticals, Inc. position peaked at $2.87M in Q2 2015.
  • 105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2015.

Based on Pictet Asset Management (UK)'s 13F filing for Q4 2015, filed 12 Feb 2016.